AG2R La Mondiale Gestion d'Actifs’s Bristol-Myers Squibb BMY Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.23M	Buy	90,829 +7,690	+9%	+$442K	0.19%	100
2026 Q1	$5.04M	Buy	83,139 +82	+0.1%	+$4.78K	0.23%	87
2025 Q4	$4.48M	Buy	83,057 +4,879	+6%	+$235K	0.2%	98
2025 Q3	$3.62M	Hold	78,178	–	–	0.19%	108
2025 Q2	$3.62M	Buy	78,178 +2,568	+3%	+$126K	0.19%	108
2025 Q1	$3.65M	Buy	+75,610	New	+$4.41M	0.2%	103

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AG2R La Mondiale Gestion d'Actifs's BMY Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Bristol-Myers Squibb (BMY) stake by 9.2% in Q2 2026, buying an estimated $442K and bringing the position to 90,829 shares worth $5.23M. The position accounts for 0.19% of the portfolio, ranked #100.

AG2R La Mondiale Gestion d'Actifs first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

AG2R La Mondiale Gestion d'Actifs held 90,829 shares of Bristol-Myers Squibb worth $5.23M as of Q2 2026.
AG2R La Mondiale Gestion d'Actifs bought 7,690 Bristol-Myers Squibb shares in Q2 2026, an estimated $442K.
Bristol-Myers Squibb made up 0.19% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #100 holding.
AG2R La Mondiale Gestion d'Actifs first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.